• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives Azaspirodecane derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives

Comprehensive Overview of tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate (CAS No. 960616-53-9)

tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate (CAS No. 960616-53-9) is a highly specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. Its unique spirocyclic structure and tert-butyl carboxylate functional group make it a valuable intermediate in the development of bioactive molecules. Researchers and chemists frequently search for this compound due to its relevance in drug discovery, medicinal chemistry, and catalysis, aligning with the growing demand for novel therapeutic agents and sustainable synthetic methodologies.

The compound's 1,8-diazaspiro[5.6]dodecane core is a key structural motif in modern organic chemistry, often explored for its conformational rigidity and ability to enhance molecular interactions. This feature has sparked interest in its potential applications for central nervous system (CNS) drug development, a trending topic in pharmaceutical research. Recent studies highlight the importance of spirocyclic compounds in addressing challenges like blood-brain barrier permeability and receptor selectivity, making tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate a subject of frequent inquiries in academic and industrial forums.

From a synthetic perspective, the tert-butyl ester group in this compound offers excellent stability and versatility, enabling its use in multi-step reactions such as peptide coupling and cross-coupling reactions. These attributes align with the increasing focus on green chemistry and atom-economical processes, which are highly searched topics in AI-driven literature databases. The compound's compatibility with microwave-assisted synthesis and flow chemistry further enhances its appeal to researchers aiming for high-throughput and energy-efficient methodologies.

Analytical characterization of tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate typically involves advanced techniques like NMR spectroscopy, high-resolution mass spectrometry (HRMS), and X-ray crystallography. These methods are critical for verifying the compound's purity and structural integrity, which are frequently discussed in quality control and regulatory compliance contexts. The rise of AI-powered spectral analysis tools has further streamlined the identification process, making this compound a case study in the integration of computational and experimental chemistry.

In the context of intellectual property, CAS No. 960616-53-9 has been referenced in several patents related to kinase inhibitors and GPCR modulators, reflecting its significance in targeted therapy development. This aligns with the surge in searches for precision medicine and personalized therapeutics, as the pharmaceutical industry shifts toward patient-specific treatments. The compound's role in fragment-based drug design (FBDD) also makes it a recurring keyword in computational chemistry and molecular docking discussions.

Supply chain dynamics for tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate are influenced by its niche applications, with manufacturers emphasizing GMP compliance and scalable synthesis routes. These factors are critical for laboratories requiring consistent batches for high-throughput screening (HTS) campaigns, a hot topic in drug repurposing research. The compound's stability under ambient conditions also makes it a preferred choice for global distribution, addressing common logistical concerns in the fine chemicals market.

Future research directions for this compound may explore its utility in bioconjugation strategies and proteolysis-targeting chimeras (PROTACs), two rapidly evolving areas in chemical biology. Its structural features could enable the development of bifunctional molecules, a concept gaining traction in degrader technology forums. As the scientific community continues to prioritize undruggable targets, tert-Butyl 1,8-diazaspiro[5.6]dodecane-1-carboxylate may emerge as a cornerstone in innovative therapeutic platforms.

• 502649-32-3(1-Boc-3-isopropyl-piperazine)
• 625471-18-3(tert-butyl (3S)-3-aminopiperidine-1-carboxylate)
• 1000576-83-9(tert-Butyl 3-(dimethylamino)piperidine-1-carboxylate)
• 184637-48-7(tert-butyl 3-aminopiperidine-1-carboxylate)
• 188111-79-7(tert-butyl (3R)-3-aminopiperidine-1-carboxylate)
• 370069-31-1(Tert-butyl 2-(aminomethyl)piperidine-1-carboxylate)
• 177911-87-4(Tert-butyl 2-(aminomethyl)pyrrolidine-1-carboxylate)
• 392331-89-4(Tert-Butyl 3-(methylamino)piperidine-1-carboxylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)